In Reply to "Malignant Mesothelioma and Its Nonasbestos Causes"

Affiliations

¹ 1 Department of Cellular Pathology, Cardiff and Vale University Health Board, and Cardiff University, University Hospital of Wales, Cardiff, United Kingdom.
² 2 Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada.
³ 3 Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France.
⁴ 4 Department of Cellular Pathology, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
⁵ 5 Department of Pathology, Duke University Medical Center, Durham, North Carolina.

Free article

Comment

Richard L Attanoos et al. Arch Pathol Lab Med. 2019 Aug.

Free article

. 2019 Aug;143(8):911-914.

doi: 10.5858/arpa.2019-0060-LE.

¹ 1 Department of Cellular Pathology, Cardiff and Vale University Health Board, and Cardiff University, University Hospital of Wales, Cardiff, United Kingdom.
² 2 Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada.
³ 3 Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France.
⁴ 4 Department of Cellular Pathology, Cardiff and Vale University Health Board, Cardiff, United Kingdom.
⁵ 5 Department of Pathology, Duke University Medical Center, Durham, North Carolina.

No abstract available

Comment on

Malignant Mesothelioma and Its Non-Asbestos Causes.
Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Attanoos RL, et al. Arch Pathol Lab Med. 2018 Jun;142(6):753-760. doi: 10.5858/arpa.2017-0365-RA. Epub 2018 Feb 26. Arch Pathol Lab Med. 2018. PMID: 29480760 Review.
Malignant Mesothelioma and Its Nonasbestos Causes.
Finkelstein MM. Finkelstein MM. Arch Pathol Lab Med. 2019 Jun;143(6):659-660. doi: 10.5858/arpa.2018-0145-LE. Arch Pathol Lab Med. 2019. PMID: 31121110 No abstract available.